Placebo matching REGN9933, REGN7508, REGN9933, Placebo matching REGN7508
R9933-DVT-2308
Phase 2 small_molecule active
Quick answer
Placebo matching REGN9933, REGN7508, REGN9933, Placebo matching REGN7508 for Venous Thromboembolism is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Venous Thromboembolism
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active